ReviewGeriatrics (Basel, Switzerland)2022
A Narrative Review of Specialist Parkinson's Nurses: Evolution, Evidence and Expectation.
Review in Geriatrics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Protocol of the interdisciplinary and intersectoral randomized controlled trial in Parkinson patients in a specialized network in Germany: the INSPIRE Trial.Neurological research and practice · 2026Article
- Exploring the needs and preferences of older trauma patients: a qualitative study.BMC geriatrics · 2025Article
- 'Breaking the stigma': a qualitative study on how public perceptions affect individuals with Parkinson's disease - a nurse specialist perspective.BMC geriatrics · 2025Article
- Exploring the public's perception and understanding of Parkinson's disease in Ireland: a study protocol.BMC geriatrics · 2025Article
- The diagnostic pathway of Parkinson's disease: understanding patient perspectives in Australia.NPJ Parkinson's disease · 2025Article
- Integrated management of atypical parkinsonism: a home-based patient-centered healthcare delivery based on telenursing-the IMPACT study protocol.Therapeutic advances in neurological disorders · 2025Article
- Priorities in healthcare provision in Parkinson's disease from the perspective of Parkinson Nurses: A focus group study.International journal of nursing studies advances · 2024Article
- What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.Journal of neural transmission (Vienna, Austria : 1996) · 2024Review
- Mitochondrial Dysfunction in Parkinson's Disease: A Contribution to Cognitive Impairment?International journal of molecular sciences · 2024Review
- Quality of life and living with Parkinson's disease: a qualitative exploration within an Irish context.BMC neurology · 2024Article
- Old problems, new solutions: harnessing technology and innovation in Parkinson's disease-evidence and experiences from Thailand.Journal of neural transmission (Vienna, Austria : 1996) · 2024Review
- Parkinson's Nurses Are Crucial for the Management of Parkinson's Disease: 2007-2024.Journal of Parkinson's disease · 2024Review
- Delivery of Allied Health Therapies to People with Parkinson's Disease in Africa.Journal of Parkinson's disease · 2024Review
- Integrating technology into a successful apomorphine delivery program in Thailand: a 10-year journey of achievements with a five-motto concept.Frontiers in neurology · 2024Article
- Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines.Journal of neural transmission (Vienna, Austria : 1996) · 2023Review
- Infusion Therapies in the Treatment of Parkinson's Disease.Journal of Parkinson's disease · 2023Review
- Telemedicine as an Untapped Opportunity for Parkinson's Nurses Training in Personalized Care Approaches.Journal of personalized medicine · 2022Article
- Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches.Frontiers in aging neuroscience · 2022Review
- Effect of 6S refined individualized nursing management in the perioperative period of Parkinson's disease patients undergoing deep brain stimulation.Frontiers in neurologyArticle
- Initiating Apomorphine Therapy Without Antiemetic Pretreatment: Real-World Data From a Nurse-led Parkinson Disease Support Program.The Journal of neuroscience nursing : journal of the American Association of Neuroscience NursesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Extended nursing roles have existed since the 1940s. The first specialist nurse for Parkinson's disease, a complex neurodegenerative disease, was appointed in the United Kingdom (UK) in 1989. A review was undertaken using MEDLINE and Cumulative Index to the Nursing and Allied Health Literature (CINAHL), relating to the role and evidence for Parkinson's disease nurse specialists (PDNSs). PDNSs fulfil many roles. Trials of their effectiveness have failed to show a positive benefit on health outcomes, but their input appears to improve the wellbeing of people with Parkinson's. Now embedded in the UK Parkinson's multidisciplinary team, this care model has since been adopted widely, including successful dissemination of training to countries in Sub-Saharan Africa. The lack of evidence to support the benefit of PDNSs may reflect an insufficient duration and intensity of the intervention, the outcome measures selected or the need to combine PDNS input with other evidence-based interventions. Whilst the current evidence base for their effectiveness is limited, their input appears to improve subjective patient wellbeing and they are considered a vital resource in management. Better evidence in the future will support the development of these roles and may facilitate the application of specialist nurses to other disease areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.